- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1, NEJM 2022, n=2,539) Semaglutide Prescribing Information (FDA, 2025) Tirzepatide Prescribing Information (FDA, 2025) Self-Monitoring via Digital Health in Weight Loss Interventions: A Systematic Review Among Adults with Overweight or Obesity What Real Weight Tracker Users Say About Staying With It The Scale Matters Less When the Whole Week Makes Sense A weight loss tracker app only matters if it keeps someone going past week one
All GLP-1 agonist receptors, including, Wegovy have common side effects like heartburn, constipation, diarrhea, nausea, and an upset stomach
doi: 10.1016/j.ebiom.2021.103560 11 VermaNVinikYSarohaANairNURuppinEMillsGet al
In suspected resectable disease, metabolic imaging (PET-CT) is often offered to identify other metastatic sites [9], as MM often demonstrates high tracer uptake (Figs